Description | Mkt Cap | P/E | Current Ratio | Cash per Share | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | H-Rank | C-Rank | Stars |
CF | 16 B | 14 | 3.8 | 10.79 | 25 | 47 | -39 | -67 | 40 | 14 | 3 |
FMC | 7.7 B | 12 | 1.5 | 2.42 | 8.2 | 19 | -29 | 307 | 47 | 19 | 0 |
BIOX | 772 M | 11 | 1.2 | 0.66 | 10.0 | 15 | 48 | 50 | 20 | 1 | |
ICL | 6.6 B | 10.0 | 1.5 | 0.46 | 8.0 | 20 | -19 | -80 | 51 | 24 | 1 |
MOS | 10 B | 10.0 | 1.2 | 1.08 | 8.8 | 17 | -29 | -26 | 53 | 25 | 1 |
UAN | 785 M | -11 | 2.2 | 4.28 | 12 | 41 | -33 | -89 | 53 | 25 | 2 |
NTR | 26 B | 11 | 1.2 | 1.90 | 6.8 | 18 | -25 | -83 | 57 | 30 | 0 |
CTVA | 38 B | 15 | 1.6 | 3.91 | 2.0 | 18 | -3.1 | 57 | 30 | 0 | |
IPI | 253 M | -44 | 3.3 | 0.58 | 5.1 | 20 | -18 | 60 | 33 | 1 | |
SMG | 3.9 B | 18 | 2.2 | 0.44 | -13 | 10.0 | -22 | 67 | 42 | 0 | |
BHIL | 55 M | -1.2 | 1.2 | 0.23 | -20 | -10.0 | 17 | 71 | 46 | 0 | |
LVRO | 622 M | -25 | 1.1 | 6.11 | 5.0 | -1.1 | -4.8 | 72 | 48 | 0 | |
SEED | 20 M | 0.45 | 3.75 | -46 | -9.4 | 338 | 76 | 53 | 0 | ||
CGA | 40 M | 2.4 | 5.09 | -30 | -14 | -27 | 78 | 56 | 1 |
Total Records: 14. | Quotes | Help |
© George Elgin | Questions or Comments | Data last Modified 03/20/24 |
P/E | Current Ratio | Operating Margin | EBIDTA Margin | Revenue Growth | Earnings Growth | |
Best 10% | 3.3 | 12 | 41 | 338 | ||
Best 20% | 10.0 | 2.4 | 10.0 | 20 | 338 | |
Best 30% | 11 | 2.2 | 8.8 | 20 | 338 | |
mean | 12 | 1.8 | 9.1 | 22 | 134 | 307 |
median | 11 | 1.5 | 8.1 | 18 | 48 | 307 |
tr mean | 12 | 1.8 | 9.1 | 22 | 134 | 307 |
count | 8.0 | 14 | 10.0 | 10.0 | 3.0 | 1.00 |